Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes

Abstract

Possible immunogenicity of the Cas9 protein raises concerns about therapeutic applications. Here the authors identify pre-existing CD8+T-cell immunity in healthy individuals and in response modify Cas9 to remove the immunodominant epitopes.